EU-METAHEART Kickoff meeting | Belgium, 18th october 2023

EU-METAHEART Kickoff meeting | Belgium, 18th october 2023

The first meeting of the EU-METAHEART management committee (MC) took place in Brussels in October 2023, aiming to launch COST Action 22169, dedicated to the highly relevant topic of cardiovascular diseases and heart failure. This exciting meeting included plenary sessions in the morning, followed by “Action Café” dynamics in which small groups gathered in breakout discussions to explore the research aims within each working group and address vital cross-sectional topics, such as stakeholder involvement, grant awarding, training schools, and defining a communication strategy.

In the afternoon, the group reconvened for a debriefing from the breakout sessions. This was followed by elections for key positions, including chair, vice chair, and other essential roles. The meeting concluded with a discussion on the COST Action structure and how to distribute the budget for the first year’s planned activities.

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage

New Insights into Cardiac Amyloidosis Mechanisms and Therapies

WG2 Online Meeting

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

New Research Highlight from EU-METAHEART consortium “Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage” by Panagiota-Efstathia Nicolau, Ioanna Andreadou and collaborators. The study...
A recent publication co-authored by core members of the EU-METAHEART COST Action focuses on the multifaceted mechanisms driving cardiac amyloidosis and explores potential therapeutic avenues. The paper, entitled “Mechanisms of...
As WG2 leaders, Luca Liberale, Bruno Podesser, and Gerd Heusch presented the scope and objectives of the METAHEART COST action, focusing on WG2 activities. The update covered recent group developments...
Dear colleagues, For a recently approved grant, I am currently looking for a post-doc with expertise on data science in exercise/muscle physiology, with a specific focus on Long COVID. The postdoc...
The MDC offers a highly vibrant scientific environment, with state-of-the-art infrastructure for immunological platforms such as flow cytometry, single-cell transcriptomics, spatial transcriptomics, metabolomics and proteomics, imaging, and in vivo work....
The 1st paper of the EU-METAHEART COST Action was published in European Heart Journal: https://doi.org/10.1093/eurheartj/ehae457 Take a look!